Cancer Center Clinical Trials & Research

The Clinical Research Unit of CancerCenters of the Carolinas, in partnership with Greenville Hospital Cancer Center, is pleased to announce an expansion of their immunobiologic program. Recently approved by the Western Institutional Biosafety Committee, the Clinical Research Unit is now conducting early phase trials utilizing gene-based therapies for a variety of malignancies including lung, colon, and pancreatic cancers.

Gene therapy involves taking virus cells that have been neutralized (no longer can spread disease) to replace a sequence of DNA that created cancer cells. As this section of DNA is replaced, cancer cells become normal cells.

To receive approval to conduct gene therapy trials, the CRU had to meet stringent criteria, including the following:

  • Skilled staff of oncologists, scientists, oncology nurses, and others with expert training and experience in conducting early clinical trials
  • A self-contained, state-of-the-art facility that meets the highest safety standards for biological research and patient safety
  • Proven reputation in conducting efficient and expertly documented clinical trials

For more information about phase I trials, please call 864-679-3966.

Upcoming Breast Cancer Clinical Trial

The provision of NCI based clinical trials is a hallmark of the GHS Breast Multidisciplinary Center (MDC) and Cancer Centers of the Carolinas. We are proud to have played a key role in previous breast and colon cancer prevention studies. Later this fall we will offer participation in a new nationwide breast cancer prevention study.

For additional information, contact Claudette Phinney at 864-679-3914.

Greenville Hospital System Institutional Review Committees monitor the administration of all clinical research trials at the hospital system and approves new trials before patients are enrolled. Our dedicated researchers collaborate with CancerCenters of the Carolinas and the Greenville Community Clinical Oncology Program (CCOP), as designated by the National Cancer Institute (NCI). For more information about NCI trials, please call 864-679-3966, or click on the link below.

NCI Search Engine for Clinical Trials